Purchase Order 75N92E24P00066
- Not listed
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This federal contract award was made by the National Human Genome Research Institute, a civilian agency, to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The $84,000 firm-fixed price purchase order is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and support services. Pacific Biosciences has established itself as a key supplier of specialized long-read sequencing solutions to...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This federal contract award to Pacific Biosciences of California, Inc. is for the renewal of a Service Contract valued at $84,000.00. The contract is a Firm Fixed Price Purchase Order with the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by various federal agencies to support genomic research...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a for-profit manufacturer of genomic sequencing equipment and consumables. The $363,000.00 firm-fixed-price purchase order is for the provision of a Sequel Instrument, which is part of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing technology. This award was not set aside for any specific business type. Pacific...
- The U.S. Department of Agriculture's Agricultural Research Service Field Research Implementation and Information Delivery awarded a firm-fixed-price delivery order to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and supplies, to provide its proprietary Sequel IIe DNA/RNA sequencing systems, reagents, and associated consumables. The $612,000 award, which does not have a set-aside designation, has a performance period through May 16, 2023 and supports the...
- This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of a single molecule, real-time (SMRT) long-read DNA sequencer and associated installation, training, and shipping services. The total potential value of the contract is $397,500. This procurement was conducted as a full and open competition, with no set-aside designation. Pacific Biosciences is an established provider of specialized sequencing equipment and consumables to various U.S. government agencies,...
- This definitive federal contract award, valued at $367,500.00, was issued by the Plains Area agency to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The contract is for the delivery of Pacific Biosciences' proprietary Sequel System (911) DNA/RNA sequencing platform and associated consumables. This contract was not set aside for any socioeconomic category. Pacific Biosciences holds two significant Indefinite Delivery Indefinite Quantity (IDIQ)...
- This contract award to Pacific Biosciences of California, Inc. is for the provision of a PacBio Sequel System 8M Upgrade. The contract, valued at $220,000.00, was awarded on a firm fixed price basis by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel...
- This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of SMRTBELL PREP KIT 3.0, a specialized sequencing consumable, at a firm fixed price of $23,873.82. The award was made by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are widely utilized by federal agencies to support genomic research initiatives. The company has established multiple Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicles with the U.S. Department of Agriculture and the Food and Drug Administration, valued at $13.5 million and $1 million respectively, to provide specialized sequencing instruments, reagents, and services to support their mission-critical programs. This latest contract award further demonstrates the agency's continued reliance on Pacific Biosciences' proprietary long-read sequencing technology to advance their research goals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 1/9/24 |